Home
Conditions
Paraproteinemias

Clinical trial condition

Paraproteinemias

Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.

3,004 public trials 571 recruiting studies

Refine in advanced search Browse all conditions

Paraproteinemias trial results

Completed

Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

NCT00003962

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +50 more
Locations: Johns Hopkins Oncology Center Baltimore, Maryland, United States

View Trial Details

Completed

Velcade,Thalidomide, and Dexamethasone Versus Velcade and Dexamethasone Versus Velcade, Melphalan, and Prednisone

NCT00507416

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Birmingham Hematology Oncology Assciates, LLC Birmingham, Alabama, United States

Desert Oasis Cancer Center Casa Grande, Arizona, United States

Northern Arizona Hematology & Oncology Associates - AOA Sedona, Arizona, United States

Arizona Oncology Associates Tucson, Arizona, United States

View all 235 locations

View Trial Details

Completed

MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia

NCT01231919

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Acute Leukemias of Ambiguous Lineage, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, +130 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Childrens Hospital of Orange County Orange, California, United States

University of California San Francisco Medical Center-Parnassus San Francisco, California, United States

Children's National Medical Center Washington D.C., District of Columbia, United States

View all 25 locations

View Trial Details

Completed

Observational Study of the Effects Intravenous Bortezomib Has on Osteoblast (Cell That is Responsible for Bone Formation) Activity in Multiple Myeloma Patients.

NCT01026701

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Not specified

View Trial Details

Completed

Exploratory Study on POL6326 in Stem Cell Mobilization

NCT01105403

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Department of Internal Medicine V Heidelberg, Germany

View Trial Details

Completed

PAV-trial: Plerixafor and Chemotherapy With Vinorelbine for Stem Cell Mobilization in Patients With Myeloma

NCT01220375

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Dep. of Medical Oncology, Bern University Hospital Bern, Switzerland

View Trial Details

Completed

Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer

NCT00265837

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +64 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Melphalan and Palifermin in Treating Patients Undergoing An Autologous Peripheral Stem Cell Transplant for Stage II or III Multiple Myeloma

NCT00482846

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chemically-Induced Disorders, +20 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Completed

Dexamethasone With or Without Thalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma

NCT00033332

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States

City of Hope Comprehensive Cancer Center Duarte, California, United States

Veterans Affairs Medical Center - Palo Alto Palo Alto, California, United States

Stanford University Medical Center Stanford, California, United States

View all 78 locations

View Trial Details

Completed

Safety Study of Lenalidomide Maintenance Therapy Post Allogeneic HCT for High-risk Multiple Myeloma

NCT00847639

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: City of Hope National Medical Center Duarte, California, United States

H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States

University of Minnesota Medical Center Minneapolis, Minnesota, United States

Hackensack University Medical Center Hackensack, New Jersey, United States

View Trial Details

Paraproteinemias

Paraproteinemias trial results

Related conditions